Switch to:
Progenics Pharmaceuticals Inc (NAS:PGNX)
EV/EBITDA
41.59 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Progenics Pharmaceuticals Inc's enterprise value is $519.74 Mil. Progenics Pharmaceuticals Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Sep. 2016 was $12.50 Mil. Therefore, Progenics Pharmaceuticals Inc's EV/EBITDA ratio for today is 41.59.

PGNX' s EV/EBITDA Range Over the Past 10 Years
Min: -132.8   Max: 233.2
Current: 41.57

-132.8
233.2

During the past 13 years, the highest EV/EBITDA Ratio of Progenics Pharmaceuticals Inc was 233.20. The lowest was -132.80. And the median was -4.00.

PGNX's EV/EBITDA is ranked lower than
76% of the 276 Companies
in the Global Biotechnology industry.

( Industry Median: 16.24 vs. PGNX: 41.57 )

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Progenics Pharmaceuticals Inc's stock price is $8.86. Progenics Pharmaceuticals Inc's earnings per share for the trailing twelve months (TTM) ended in Sep. 2016 was $0.16. Therefore, Progenics Pharmaceuticals Inc's P/E Ratio for today is 55.38.

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Progenics Pharmaceuticals Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=519.741/12.497
=41.59

Progenics Pharmaceuticals Inc's current Enterprise Value is $519.74 Mil.
Progenics Pharmaceuticals Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Sep. 2016 was -7.139 (Dec. 2015 ) + -11.965 (Mar. 2016 ) + -4.964 (Jun. 2016 ) + 36.565 (Sep. 2016 ) = $12.50 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Progenics Pharmaceuticals Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=8.86/0.16
=55.38

Progenics Pharmaceuticals Inc's share price for today is $8.86.
Progenics Pharmaceuticals Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Sep. 2016 was -0.1 (Dec. 2015 ) + -0.18 (Mar. 2016 ) + -0.08 (Jun. 2016 ) + 0.52 (Sep. 2016 ) = $0.16.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Progenics Pharmaceuticals Inc Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
ev2ebitda -19.78-8.47-4.34-1.81-1.9817.68-2.34-6.15103.98-9.16

Progenics Pharmaceuticals Inc Quarterly Data

Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16
ev2ebitda -5.4734.26103.98103.99179.87-6.95-9.16-5.90-6.9327.58
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK